LifeTech Scientific Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LFTSF research report →
Price Chart
About the company
LifeTech Scientific Corporation, established in 1999 and headquartered in Shenzhen, People's Republic of China, operates as an investment holding company. Its primary focus is the development, manufacturing, and commercialization of state-of-the-art interventional medical devices specifically designed to address cardiovascular and peripheral vascular ailments. The company structures its operations across three distinct segments: Structural Heart Diseases, Peripheral Vascular Diseases, and Cardiac Pacing and Electrophysiology.
- CEO
- Yue Hui Xie
- IPO
- 2021
- Employees
- 1,245
- HQ
- Shenzhen, CN
Get TickerSpark's AI analysis on LFTSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $1.03B
- P/E
- 88.11
- Fwd P/E
- 2.97
- PEG
- -3.75
- P/S
- 3.81
- P/B
- 1.48
- EV/EBITDA
- 14.37
- Div Yield
- 0.00%
- Gross Margin
- 76.30%
- Op Margin
- 8.43%
- Net Margin
- 4.51%
- ROE
- 1.71%
- ROIC
- 0.62%
Latest fiscal year · YoY change
- Revenue
- $1.37B+5.1%
- Gross Profit
- $1.02B+3.8%
- Op Income
- $175.88M
- Net Income
- $147.83M-33.5%
- EPS
- $0.03-33.3%
- OCF Growth
- +70.9%
- FCF Growth
- +937.5%
- 52W High
- $0.23
- 52W Low
- $0.23
- 50D MA
- $0.23
- 200D MA
- $0.23
- Beta
- 0.31
- RSI (14)
- 100
- Avg Volume
- 64
No earnings-call transcripts are available for LFTSF yet.
- Free Float
- 81.3%
- Shares Outstanding
- 4.40B
- Float Shares
- 3.58B
Our LFTSF coverage
Recent articles, reports, and earnings notes.
No research on LFTSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LFTSF report →